NO20040267L - Anvendelse av en vaksine til aktiv immunisering mot kreft - Google Patents

Anvendelse av en vaksine til aktiv immunisering mot kreft

Info

Publication number
NO20040267L
NO20040267L NO20040267A NO20040267A NO20040267L NO 20040267 L NO20040267 L NO 20040267L NO 20040267 A NO20040267 A NO 20040267A NO 20040267 A NO20040267 A NO 20040267A NO 20040267 L NO20040267 L NO 20040267L
Authority
NO
Norway
Prior art keywords
vaccine
against cancer
immunization against
active immunization
active
Prior art date
Application number
NO20040267A
Other languages
English (en)
Norwegian (no)
Inventor
Hans Loibner
Gottfried Himmler
Hellmut Samonigg
Original Assignee
Igeneon Krebs Immuntherapie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29425362&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20040267(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Igeneon Krebs Immuntherapie filed Critical Igeneon Krebs Immuntherapie
Publication of NO20040267L publication Critical patent/NO20040267L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20040267A 2002-05-21 2004-01-20 Anvendelse av en vaksine til aktiv immunisering mot kreft NO20040267L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0077402A AT500647A1 (de) 2002-05-21 2002-05-21 Verwendung eines impfstoffes
PCT/AT2003/000148 WO2003097092A1 (de) 2002-05-21 2003-05-20 Verwendung eines impfstoffes zur aktiven immunisierung gegen krebs

Publications (1)

Publication Number Publication Date
NO20040267L true NO20040267L (no) 2004-03-18

Family

ID=29425362

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20040267A NO20040267L (no) 2002-05-21 2004-01-20 Anvendelse av en vaksine til aktiv immunisering mot kreft

Country Status (6)

Country Link
US (1) US20050169929A1 (de)
EP (1) EP1506012A1 (de)
AT (1) AT500647A1 (de)
AU (1) AU2003229346A1 (de)
NO (1) NO20040267L (de)
WO (1) WO2003097092A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0221574D0 (en) * 2002-09-17 2002-10-23 Isis Innovation Treatments
AT500651B9 (de) * 2003-05-27 2010-04-15 Altropus Gmbh Aktiv immunisierender antikörper
WO2007008943A2 (en) 2005-07-08 2007-01-18 Xencor, Inc. Optimized anti-ep-cam antibodies
WO2008021493A2 (en) * 2006-08-18 2008-02-21 Huiru Wang A process for identification of molecular mimicry and the uses thereof
ES2555858T3 (es) * 2009-03-24 2016-01-11 Transgene Sa Biomarcador para el control de pacientes
CN102483405B (zh) * 2009-07-10 2015-12-02 特朗斯吉有限公司 用于选择患者的生物标志物及相关方法
JP2022520067A (ja) * 2019-02-08 2022-03-28 ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド モノホスホリルリピドａリポソーム系癌ワクチン

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194384A (en) * 1987-04-23 1993-03-16 Bystryn Jean Claude Method for preparing human meloma vaccine
US5194383A (en) * 1991-11-21 1993-03-16 National Science Council Of Republic Of China Process for making L-aminoacylase
US5478556A (en) * 1994-02-28 1995-12-26 Elliott; Robert L. Vaccination of cancer patients using tumor-associated antigens mixed with interleukin-2 and granulocyte-macrophage colony stimulating factor
US5792455A (en) * 1996-03-21 1998-08-11 Sloan-Kettering Institute For Cancer Research Anti-idiotypic antibody vaccines
RU2112543C1 (ru) * 1996-09-26 1998-06-10 Александр Григорьевич Хоменко Иммуномодулирующее лекарственное средство
BRPI9809391B8 (pt) * 1997-04-14 2021-05-25 Amgen Res Munich Gmbh processo para a produção de um receptor de antígeno anti-humano, anticorpo humano e composição farmacêutica
US6274143B1 (en) * 1997-06-13 2001-08-14 Malaya Chatterjee Methods of delaying development of HMFG-associated tumors using anti-idiotype antibody 11D10
HU226150B1 (en) * 1999-01-13 2008-05-28 Igeneon Krebs Immuntherapie Use of antibodies for anticancer vaccination
AU5286999A (en) * 1999-07-23 2001-02-13 Glaxo Group Limited Combination of an anti-ep-cam antibody with a chemotherapeutic agent
US6322986B1 (en) * 2000-01-18 2001-11-27 Albany Medical College Method for colorectal cancer prognosis and treatment selection
AU2001290801A1 (en) * 2000-09-12 2002-03-26 Zycos Inc. Peptide epitopes recognized by antigen specific cd4+ t lymphocytes

Also Published As

Publication number Publication date
WO2003097092A1 (de) 2003-11-27
EP1506012A1 (de) 2005-02-16
AU2003229346A1 (en) 2003-12-02
US20050169929A1 (en) 2005-08-04
AT500647A1 (de) 2006-02-15

Similar Documents

Publication Publication Date Title
IS7670A (is) Samsett meðferð fyrir offjölgunar sjúkdóma
ATE403432T1 (de) Pharmazeutische darreichungsform mit gesteuerter freigabe eines cholesterylester- transferproteininhibitors
IS7691A (is) Lyfjasamsetningar til að meðhöndla æxli
CY2013036I2 (el) Συνθεσεις εμβολιου κατα της ναϊσσερια, που περιεχουν εναν συνδυασμο αντιγονων
NO20053076D0 (no) Farmasoytisk formulering med en uloselig aktiv forbindelse.
IS8398A (is) Lyfjasamsetningar til að meðhöndla æxli
DK1373259T3 (da) Pyridazinonaldosereduktaseinhibitorer
AU2003213968A1 (en) Device for the temporary splinting of toes
EP1469812A4 (de) Orale insulintherapie
NO20030713D0 (no) Oral faststoffdose vaksine
EP1423141A4 (de) Vakzine
IS7481A (is) Epóthílon til gjafar um munn
DZ3219A1 (fr) Vaccin
DK1608362T3 (da) Stabiliseret farmaceutisk præparat indeholdende en amorf aktiv forbindelse
EP1800693A4 (de) Adjuvante therapie mit verwendung von anti-glypican-3-antikörper
IS7831A (is) Bóluefni
NO20043832L (no) Oral fast losningsformulering av en darlig vannloselig aktiv substans
NO20040267L (no) Anvendelse av en vaksine til aktiv immunisering mot kreft
EP1565583A4 (de) Hiv-vakzine-formulierungen
EA200500101A1 (ru) Лекарственное средство для коррекции патологических иммунных реакций
FI20000780L (fi) Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi
DE60336999D1 (de) Melatonin enthaltende pharmazeutische formulierung
IS7312A (is) Aðferð til að ákvarða lífvirkni defíbrótíðs
DE60328408D1 (de) Impfstoff
DK1649824T3 (da) Hjælpeanordning til segmental distalisation til ortodontiske behandlinger

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application